Macrogenics

Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease

placeRockville, Maryland, United States calendar_todayFounded 2000 groups339 employees language macrogenics.com

Registered entities

Social engagement

Social engagement: 17.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

31 investors on record; lead investors include Nextech Venture, Ventures West; 6 have since exited.

Investor typeCountShare
Venture capital1342%
Private equity1032%
Other / undisclosed826%

Recent activity

23 Jun 2026
Milestone
regulatory
19 May 2026
Event
Stifel Financial Corp. 2026 Virtual Oncology Forum
9 Jan 2026
Event
44th Annual J.P. Morgan Healthcare Conference
Coming soon